Thr304
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr304  -  p53 (human)

Site Information
HELPPGStkRALPNN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 50310600

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 2 ) , mutation of modification site ( 1 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Disease tissue studied:
neuroblastoma ( 2 )
Relevant cell line - cell type - tissue:
'neuron, cortical' ( 2 ) , BV2 (microglia) ( 1 ) , SH-SY5Y (neural crest) ( 2 ) , SN4741 (neuron) ( 1 )

Upstream Regulation
Putative in vivo kinases:
LRRK2 (human) ( 2 )
Kinases, in vitro:
LRRK2 (human) ( 2 )

Downstream Regulation
Effects of modification on p53:
intracellular localization ( 2 )
Effects of modification on biological processes:
apoptosis, induced ( 1 , 2 ) , transcription, induced ( 1 , 2 ) , translation, induced ( 1 )

References 

1

Ho DH, Seol W, Eun JH, Son IH (2017) Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity. Biochem Biophys Res Commun 482, 1088-1094
27914807   Curated Info

2

Ho DH, et al. (2015) Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression. Mol Brain 8, 54
26384650   Curated Info